Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
85.94
-2.57 (-2.90%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Blueprint Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
5,4925,5415,6072,6216,3026,250
Upgrade
Market Cap Growth
-1.19%-1.19%113.92%-58.41%0.83%58.57%
Upgrade
Enterprise Value
5,3525,3915,5542,0965,0925,584
Upgrade
Last Close Price
85.9487.2292.2443.81107.11112.15
Upgrade
PE Ratio
-----19.91
Upgrade
PS Ratio
10.6210.8922.4912.8535.007.87
Upgrade
PB Ratio
18.3318.5542.935.096.494.25
Upgrade
P/TBV Ratio
18.5518.5542.935.096.494.25
Upgrade
P/FCF Ratio
----16.28
Upgrade
P/OCF Ratio
----16.15
Upgrade
EV/Sales Ratio
10.5210.6022.2710.2728.287.04
Upgrade
EV/EBITDA Ratio
----17.71
Upgrade
EV/EBIT Ratio
----18.09
Upgrade
EV/FCF Ratio
----14.55
Upgrade
Debt / Equity Ratio
2.422.425.931.310.120.06
Upgrade
Debt / EBITDA Ratio
-----0.27
Upgrade
Debt / FCF Ratio
-----0.23
Upgrade
Asset Turnover
0.460.460.210.160.120.65
Upgrade
Inventory Turnover
1.161.160.501.041.69-
Upgrade
Quick Ratio
2.662.663.515.363.436.86
Upgrade
Current Ratio
2.852.853.765.713.707.09
Upgrade
Return on Equity (ROE)
-31.26%-31.26%-157.13%-75.07%-52.78%32.45%
Upgrade
Return on Assets (ROA)
-11.89%-11.89%-25.34%-25.82%-27.01%15.91%
Upgrade
Return on Capital (ROIC)
-13.75%-13.75%-29.05%-29.60%-30.38%18.20%
Upgrade
Return on Capital Employed (ROCE)
-----19.40%
Upgrade
Earnings Yield
-1.22%-1.21%-9.04%-21.27%-10.22%5.02%
Upgrade
FCF Yield
-3.59%-3.56%-8.08%-19.50%-4.79%6.14%
Upgrade
Buyback Yield / Dilution
-3.80%-3.80%-1.54%-1.92%-4.18%-17.44%
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q